Schedule of Segment Reporting Information, by Segment [Table Text Block] |
Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows: | | | | | | | | | | | | | | | | | | Quarter Ended December 31, | | Nine Months Ended December 31, | (In millions) | 2014 | | 2013 | | 2014 | | 2013 | Revenues | | | | | | | | Distribution Solutions (1) | | | | | | | | North America pharmaceutical distribution and services | $ | 37,398 |
| | $ | 32,060 |
| | $ | 106,850 |
| | $ | 92,808 |
| International pharmaceutical distribution and services | 7,288 |
| | — |
| | 22,207 |
| | — |
| Medical-Surgical distribution & services | 1,564 |
| | 1,462 |
| | 4,471 |
| | 4,286 |
| Total Distribution Solutions | 46,250 |
| | 33,522 |
| | 133,528 |
| | 97,094 |
| | | | | | | | | Technology Solutions - products and services | 755 |
| | 814 |
| | 2,293 |
| | 2,466 |
| Total Revenues | $ | 47,005 |
| | $ | 34,336 |
| | $ | 135,821 |
| | $ | 99,560 |
| | | | | | | | | Operating profit | | | | | | | | Distribution Solutions (2) (3) (4) | $ | 785 |
| | $ | 552 |
| | $ | 2,326 |
| | $ | 1,856 |
| Technology Solutions (5) (6) | 111 |
| | 47 |
| | 304 |
| | 294 |
| Total | 896 |
| | 599 |
| | 2,630 |
| | 2,150 |
| Corporate Expenses, Net (7) | (103 | ) | | (112 | ) | | (317 | ) | | (307 | ) | Interest Expense | (97 | ) | | (69 | ) | | (297 | ) | | (187 | ) | Income from Continuing Operations Before Income Taxes | $ | 696 |
| | $ | 418 |
| | $ | 2,016 |
| | $ | 1,656 |
|
| | (1) | Revenues derived from services represent less than 2% of this segment’s total revenues. |
| | (2) | Operating profit for the third quarter and first nine months of 2014 includes AWP litigation charges of $18 million and $68 million, which were recorded in operating expenses. |
| | (3) | Operating profit for the third quarter and first nine months of 2015 includes last-in-first-out (“LIFO”) inventory charges of $95 million and $287 million. Operating profit for the third quarter and first nine months of 2014 includes LIFO inventory charges of $142 million and $186 million. The charges were all recorded in cost of sales. |
| | (4) | Operating profit for the third quarter and first nine months of 2015 includes $51 million and $151 million of acquisition-related expenses, and $16 million and $38 million for the third quarter and first nine months of 2014. |
| | (5) | Operating profit for the first nine months of 2015 includes a charge of $34 million related to the retained workforce business within our International Technology business. |
| | (6) | Operating profit for the third quarter of 2014 includes product alignment charges, integration-related expenses and severance charges totaling $57 million, of which $34 million was recorded in cost of sales and $23 million was recorded in operating expenses. Operating profit for the first nine months of 2014 includes product alignment charges, integration-related expenses and severance charges totaling $60 million, of which $34 million was recorded in cost of sales and $26 million was recorded in operating expenses. |
| | (7) | Corporate expenses, net, for the third quarter and first nine months of 2015 include $1 million and $11 million of acquisition-related expenses and $25 million and $26 million for the third quarter and first nine months of 2014. |
|